title: [Osteoporosis: therapy in interface management].
abstract: Osteoporosis is defined as a systemic bone disorder with decreased bone strength and an increased susceptibility for fragility fractures. In particular elderly people face an increased fracture risk. Fracture stabilisation by different methods of osteosynthesis and fast remobilisation has become standard procedures after a fragility fracture due to osteoporosis. However, only a small group of patients receive osteoporosis drug therapy with the aim to reduce the rate of further fractures. In literature this has been described as "osteoporosis care gap". In the past, various projects have been performed in order to overcome this problem of osteoporosis care after fragility fractures. The article presents the current problems in daily routine concerning the initiation of an osteoporosis therapy after a fracture. A simple concept of necessary procedures and questions is presented as a possible solution for the interface management of osteoporosis drug therapy after fragility fractures. In addition, current osteoporosis therapies are presented in the view of care for geriatric patients.
authors.affiliation: 1. Medizinische Abteilung und Ludwig Boltzmann-Institut für Osteologie, Hanusch-Krankenhaus, Heinrich-Collin Str. 30, 1140, Wien, Österreich, peter.mikosch@osteologie.at.
authors.forename: Peter
authors.initials: P
authors.lastname: Mikosch
authors.forename: Markus
authors.initials: M
authors.lastname: Gosch
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D050071:Bone Density Conservation Agents / Q000008:administration & dosage*; D003299:Cooperative Behavior; D019317:Evidence-Based Medicine; D006620:Hip Fractures / Q000517:prevention & control; D006801:Humans; D033183:Interdisciplinary Communication; D010024:Osteoporosis / Q000188:drug therapy*; D058866:Osteoporotic Fractures / Q000517:prevention & control*; D011183:Postoperative Complications / Q000188:drug therapy; D012307:Risk Factors; D016103:Spinal Fractures / Q000517:prevention & control
chemical_list: D050071:Bone Density Conservation Agents